These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Relationship of platelet specific proteins and other factors to atherosclerosis in various stages of hypertension. Ding YA; Chou TC; Huan R; Lin KC Clin Exp Hypertens A; 1991; 13(8):1329-41. PubMed ID: 1836985 [TBL] [Abstract][Full Text] [Related]
10. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease. Ravindran R; Krishnan LK Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group. Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252 [TBL] [Abstract][Full Text] [Related]
12. Exogenous L-arginine and HDL can alter LDL and ox-LDL-mediated platelet activation: using platelet P-selectin receptor numbers. Sener A; Enc E; Ozsavci D; Vanizor-Kural B; Yanikkaya-Demirel G; Oba R; Uras F; Demir M Clin Appl Thromb Hemost; 2011; 17(6):E79-86. PubMed ID: 21078607 [TBL] [Abstract][Full Text] [Related]
13. Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients. Csongrádi É; Nagy B; Fulop T; Varga Z; Karányi Z; Magyar MT; Oláh L; Papp M; Facskó A; Kappelmayer J; Paragh G; Káplár M Thromb Haemost; 2011 Oct; 106(4):683-92. PubMed ID: 21866298 [TBL] [Abstract][Full Text] [Related]
14. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension]. Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791 [TBL] [Abstract][Full Text] [Related]
15. Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus. Nomura S; Kanazawa S; Fukuhara S J Hum Hypertens; 2002 Aug; 16(8):539-47. PubMed ID: 12149659 [TBL] [Abstract][Full Text] [Related]
16. Activation of platelets by in vitro whole blood contact with materials: increases in microparticle, procoagulant activity, and soluble P-selectin blood levels. Gemmell CH J Biomater Sci Polym Ed; 2001; 12(8):933-43. PubMed ID: 11718486 [TBL] [Abstract][Full Text] [Related]
17. Impact of diabetes on platelet activation in different manifestations of atherosclerosis. Gremmel T; Kopp CW; Seidinger D; Koppensteiner R; Steiner S; Panzer S Swiss Med Wkly; 2013; 143():w13800. PubMed ID: 23740526 [TBL] [Abstract][Full Text] [Related]
18. Soluble P-selectin levels in diabetes mellitus patients with coronary artery disease. Aref S; Sakrana M; Hafez AA; Hamdy M Hematology; 2005 Jun; 10(3):183-7. PubMed ID: 16019467 [TBL] [Abstract][Full Text] [Related]
19. Effects of selective LDL apheresis on plasma concentrations of ICAM-1, VCAM-1 and P-selectin in diabetic patients with arteriosclerosis obliterans and receiving maintenance hemodialysis. Utsumi K; Kawabe M; Hirama A; Ueda K; Kamada Y; Arii K; Komaba Y; Katsura K; Iino Y; Katayama Y Clin Chim Acta; 2007 Feb; 377(1-2):198-200. PubMed ID: 17126824 [TBL] [Abstract][Full Text] [Related]
20. Modification of Pulsed Electric Field Conditions Results in Distinct Activation Profiles of Platelet-Rich Plasma. Frelinger AL; Gerrits AJ; Garner AL; Torres AS; Caiafa A; Morton CA; Berny-Lang MA; Carmichael SL; Neculaes VB; Michelson AD PLoS One; 2016; 11(8):e0160933. PubMed ID: 27556645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]